Cargando…

ODP415 Inclusion Health Clinic: Gender-Affirming Hormone Therapy & Surgery Booklet and Review of Efficacy in Patient-Provider Encounters

While gender-inclusive health has been a growing field, comprehensive information on the topic has lacked for both patients and providers. The "Inclusion Health Clinic (IHC) Gender-Affirming Hormone Therapy & Surgery" booklet, modelled after other Froedtert Health resources and created...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pulsiano, Sune Wolf, Sarvaideo, Jenna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625560/ http://dx.doi.org/10.1210/jendso/bvac150.1371

Ejemplares similares

Two Transgender Men Receiving Subdermal Testosterone Pellets for Gender Affirmation
por: Wolf Pulsiano, Sune L., et al.
Publicado: (2023)

ODP414 Incidence of Suicidal Events in Transgender Patients with Initiation of Gender Affirming Hormone Therapy
por: Elliott, Karma-Jaya, et al.
Publicado: (2022)

Effect on Kidney Function During Gender Affirming Hormonal Treatment in Transgender Individuals
por: Maheshwari, Arvind Kumar, et al.
Publicado: (2021)

Prolactinoma in a Male to Female Transgender Woman on Gender Affirming Hormone Therapy
por: Harned, Leighton K, et al.
Publicado: (2021)

MON-196 Gender-Affirming Hormonal Therapy and Incidence of Metabolic Syndrome and Cardiovascular Events in Patients with Gender Dysphoria
por: Mok, Mary, et al.
Publicado: (2019)

SAT422 Gender Affirming Hormone Therapy in a Non-Binary Individual with Swyer Syndrome
por: Yohannan, Jiby M, et al.
Publicado: (2023)

ODP148 GENDER AFFIRMING HORMONE THERAPY AND SPONTANEOUS CORONARY ARTERY DISSECTION
por: Yogeswaran, Vidhushei, et al.
Publicado: (2022)

Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
por: Da Silva, Eliane Dias, et al.
Publicado: (2021)

“It Wasn’t for the Sake of Me and My Mental Health”: Transgender People’s Perspective on the Role of Mental Health Providers in Initiating Gender-Affirming Hormones - a Qualitative Study
por: Maksutova, Mariam, et al.
Publicado: (2021)

PMON280 Effect of Gender Affirming Hormone Therapy (GAHT) on Adipose Tissue Morphology and Metabolism in Transgender Individuals
por: Shah, Manasi S, et al.
Publicado: (2022)

ODP600 Is this a case of surreptitious hormonal supplements?
por: Rimal, Priya, et al.
Publicado: (2022)

SUN-210 Testosterone Replacement Therapy Implicated in Osteonecrosis
por: Yang, Almira, et al.
Publicado: (2019)

Stability of Weekly Intramuscular Estradiol Cypionate in a Transgender Woman
por: Calzada, Stephanie, et al.
Publicado: (2021)

Cardiovascular Risk Factors in Transgender Women Undergoing Long-Term Gender-Affirming Hormone Therapy: A Cross-Sectional Study
por: Alvares, Leonardo A M, et al.
Publicado: (2021)

FRI431 Erythrocytosis Associated With Oral Testosterone Replacement
por: Engel, Ashley A, et al.
Publicado: (2023)

MON-195 Trans-transgender Female: Gender Identity Reversal Following Irreversible Gender Affirming Surgeries
por: Korpaisarn, Sira, et al.
Publicado: (2019)

ODP410 Exposure to Transgender Teaching in Internal Medicine Residents and Established Providers
por: Malek, Rana, et al.
Publicado: (2022)

RF34 | PMON276 The Effect of Gender Affirming Hormone Therapy (GAHT) on Non-Conventional Cardiovascular Risk Markers in Transgender Men: A Systematic Review
por: Moreira Allgayer, Roberta Martins Costa, et al.
Publicado: (2022)

FRI415 Patient Preference And Proof-of-concept For A Once-daily Follicle Stimulating Hormone (FSH) Biosimilar Delivered Via An Orally Ingestible Robotic Pill (RT-112)
por: Yamaguchi, Alyson, et al.
Publicado: (2023)

OR25-4 Modulatory Effects of Estradiol on the Resting-State Functional Connectivity in Transwomen Following Gender Affirming Surgery
por: Schneider, Maiko, et al.
Publicado: (2019)

SUN-LB9 Pharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women
por: Doll, Elizabeth E, et al.
Publicado: (2020)

ODP400 A Mutation in the Gonadotropin Releasing Hormone Receptor Associated with Congenital Hypogonadotropic Hypogonadism with Absence of Uterus and Ovaries
por: Alabi, Omolabake, et al.
Publicado: (2022)

ODP406 Effects of hormone replacement therapy on memory cognitive function in postmenopausal women: a systematic review and meta-analysis
por: Chen, Yan, et al.
Publicado: (2022)

A Cross Sectional Analysis of the Prevalence of Co-Morbidities in Older Transgender Individuals Receiving Hormone Affirming Therapy in Comparison With the General Population
por: Breda, Ido, et al.
Publicado: (2021)

ODP642 Differences in hormonal profiles and vitamin D status depending on the insulin sensitivity status in women with polycystic ovary syndrome (PCOS).
por: Ozga-Piszczek, Katarzyna, et al.
Publicado: (2022)

ODP403 Diversity of Estrogen-Responsive Genes in Endometriotic Lesions
por: Izawa, Masao, et al.
Publicado: (2022)

ODP422 PCOS is Associated with Increased Incidence of Co-morbidities
por: Vine, Donna, et al.
Publicado: (2022)

ODP428 The Effects of Asprosin Pubertal Maturation in Female Rats
por: OZ, Zeynep Dila, et al.
Publicado: (2022)

Sexual & reproductive health information on minor consent forms for pubertal suppression and gender affirming hormones
por: Taylor, Julia, et al.
Publicado: (2023)

ODP431 Adiposity in menstrual dysfunction and the role of laboratory testing in diagnosis
por: Fazeli, Pouneh, et al.
Publicado: (2022)

ODP404 Effects of Empagliflozin on Serum Androgens Levels in Men Without Diabetes
por: Kosinski, Christophe, et al.
Publicado: (2022)

ODP412 High Frequency of Erythrocytosis in Hypogonadal Men on Testosterone Replacement Therapy
por: Pérez-Luis, Jesús, et al.
Publicado: (2022)

ODP424 Postprandial Adipose Insulin Resistance in Adolescent Girls with PCOS and Obesity
por: Finn, Erin, et al.
Publicado: (2022)

OR25-4 Active Testosterone Treatment Impairs In Vitro Fertilization (IVF) Outcomes in a Female Mouse Model for Gender-Affirming Testosterone with Improvement in Outcomes Following Cessation of Testosterone Treatment
por: Moravek, Molly B, et al.
Publicado: (2022)

ODP427 The Concomitant Existence of Turner Syndrome and Non-classic Congenital Adrenal Hyperplasia
por: Go, Hanah, et al.
Publicado: (2022)

ODP405 Effects of Gonadotrope-Specific Knockout of Creb on HPG Axis Function in Mice
por: Hausken, Krist, et al.
Publicado: (2022)

ODP430 Unusual Complication after a controlled ovarian stimulation presenting as ascites
por: Ortiz, Yineli, et al.
Publicado: (2022)

Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
por: Aranda, Gloria, et al.
Publicado: (2021)

ODP437 Assement of the behavior of the transgender population in the face of social isolation due to COVID-19
por: Togni, Bianca, et al.
Publicado: (2022)

ODP401 A new FGFR1 mutation causing Idiopathic Hypogonadotropic Hypogonadism and Polydactyly
por: Espinosa, Luis Borges, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oiv7jsm67kfm6ajctdk189cudu